1![Tuberculosis / Latent tuberculosis / Tuberculosis diagnosis / Tuberculosis management / GeneXpert MTB/RIF / Multi-drug-resistant tuberculosis / Mantoux test / QuantiFERON / Isoniazid / BCG vaccine / DOTS / Rifabutin Tuberculosis / Latent tuberculosis / Tuberculosis diagnosis / Tuberculosis management / GeneXpert MTB/RIF / Multi-drug-resistant tuberculosis / Mantoux test / QuantiFERON / Isoniazid / BCG vaccine / DOTS / Rifabutin](/pdf-icon.png) | Add to Reading ListSource URL: chfs.ky.govLanguage: English - Date: 2016-08-15 08:47:02
|
---|
2![301030_dec14-CSUmatters_113.indd 301030_dec14-CSUmatters_113.indd](https://www.pdfsearch.io/img/01e362dccc08f2662057a241f10903db.jpg) | Add to Reading ListSource URL: www.president.colostate.eduLanguage: English - Date: 2014-12-29 15:39:02
|
---|
3![Chemistry / Extensively drug-resistant tuberculosis / Tuberculosis treatment / Antiretroviral drug / AIDS / Rifabutin / Efavirenz / Nevirapine / Multi-drug-resistant tuberculosis / Tuberculosis / Medicine / Health Chemistry / Extensively drug-resistant tuberculosis / Tuberculosis treatment / Antiretroviral drug / AIDS / Rifabutin / Efavirenz / Nevirapine / Multi-drug-resistant tuberculosis / Tuberculosis / Medicine / Health](/pdf-icon.png) | Add to Reading ListSource URL: www.union-imdp.orgLanguage: English - Date: 2014-08-05 04:22:02
|
---|
4![](https://www.pdfsearch.io/img/ac9852e04c9583115d273e84712b3a01.jpg) | Add to Reading ListSource URL: www.chp.gov.hkLanguage: English - Date: 2015-04-16 00:14:26
|
---|
5![Research articles Extent and origin of resistance to antituberculosis drugs in the Netherlands, 1993 to 2011 C Ruesen ()1, A B van Gageldonk-Lafeber1, G de Vries1,2, C G Erkens2, J van Rest1,2, H Research articles Extent and origin of resistance to antituberculosis drugs in the Netherlands, 1993 to 2011 C Ruesen ()1, A B van Gageldonk-Lafeber1, G de Vries1,2, C G Erkens2, J van Rest1,2, H](https://www.pdfsearch.io/img/4de0ad7a93490df49dd6b33f61e6c3cc.jpg) | Add to Reading ListSource URL: www.eurosurveillance.orgLanguage: English - Date: 2014-03-26 09:09:49
|
---|
6![Abstract Book: 41st World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease Abstract Book: 41st World Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease](https://www.pdfsearch.io/img/9c1b54dd366461db0bdfbd06bb63ed56.jpg) | Add to Reading ListSource URL: www.theunion.orgLanguage: English - Date: 2013-11-14 18:15:08
|
---|
7![Microparticles specific for lung delivery: in-vivo drug distribution in monkeys # Verma * Microparticles specific for lung delivery: in-vivo drug distribution in monkeys # Verma *](https://www.pdfsearch.io/img/f273fdc28c79059c170bdff603003054.jpg) | Add to Reading ListSource URL: precedings.nature.comLanguage: English |
---|
8![TB ISSUES AND UPDATES Dominic Gaziano, MD, FCCP Medical Director WV Division of TB Elimination WV Infectious Disease Symposium TB ISSUES AND UPDATES Dominic Gaziano, MD, FCCP Medical Director WV Division of TB Elimination WV Infectious Disease Symposium](https://www.pdfsearch.io/img/1f49d6306625e70b19d9e5f2f2782106.jpg) | Add to Reading ListSource URL: www.dhhr.wv.govLanguage: English - Date: 2015-01-16 10:19:22
|
---|
9![Self-Study Modules on Tuberculosis Treatment of Latent Self-Study Modules on Tuberculosis Treatment of Latent](https://www.pdfsearch.io/img/c774f0617bdfb2206c54ec78a53b67c2.jpg) | Add to Reading ListSource URL: www.cdc.govLanguage: English - Date: 2014-12-24 13:25:50
|
---|
10![(Rifabutin) Capsules, USP DESCRIPTION MYCOBUTIN Capsules for oral administration contain 150 mg of the rifamycin antimycobacterial agent rifabutin, USP, per capsule, along with the inactive ingredients microcrystalline c (Rifabutin) Capsules, USP DESCRIPTION MYCOBUTIN Capsules for oral administration contain 150 mg of the rifamycin antimycobacterial agent rifabutin, USP, per capsule, along with the inactive ingredients microcrystalline c](https://www.pdfsearch.io/img/49b3454b837a958aa2af4c975570213e.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-12-02 10:19:38
|
---|